
FDA advisers reject experimental stem cell treatment for ALS
A panel of outside experts for the Food and Drug Administration on Wednesday voted 17-1 that a treatment for Lou Gehrig’s disease has not been shown to be effective. Drugmaker BrainStorm Cell Therap...








